Researchers looked at how the drug Ethambutol is processed by children's bodies. They compared current World Health Organization recommendations against a new, optimized dosing method based on specific weight bands. The study focused on children between the ages of 0.2 and 15 years old.
The analysis found that many children weighing less than 25 kg received drug levels below the target range when using current guidelines. By switching to an optimized weight-based dosing system, researchers found that doses would need to increase for about 40.5% of patients. An additional 5% of children might also benefit from these adjusted doses.
It is important to note that this study used simulations to compare dosing methods. Because it was a simulation, the study did not measure actual clinical outcomes or report on side effects. These findings suggest that updating dosing guidelines could help ensure children receive enough medication to treat tuberculosis effectively.
